169 related articles for article (PubMed ID: 35947016)
81. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening.
Wang H; Wang L; Wu Z; Sun R; Jin H; Ma J; Liu L; Ling R; Yi J; Wang L; Bian J; Chen J; Li N; Yuan S; Yun J
Med Oncol; 2014 Dec; 31(12):298. PubMed ID: 25367852
[TBL] [Abstract][Full Text] [Related]
82. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
Zhao Z; Zhang C; Zhao Q
Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
[No Abstract] [Full Text] [Related]
83. An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool.
Muretto P; Graziano F; Staccioli MP; Barbanti I; Bartolucci A; Paolini G; Giordano D; Testa E; De Gaetano A
Ann Oncol; 2003 Jan; 14(1):105-9. PubMed ID: 12488301
[TBL] [Abstract][Full Text] [Related]
84. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
85. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
[TBL] [Abstract][Full Text] [Related]
86. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
87. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
[TBL] [Abstract][Full Text] [Related]
88. Feasibility of Plasma-Methylated
Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
[TBL] [Abstract][Full Text] [Related]
89. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
90. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
91. Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis.
Yan J; Shao Y; Lu H; Ye Q; Ye G; Guo J
Dig Dis Sci; 2022 Aug; 67(8):3753-3762. PubMed ID: 34424459
[TBL] [Abstract][Full Text] [Related]
92. Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.
Cirak Y; Furuncuoglu Y; Yapicier O; Alici S; Argon A
Int J Clin Exp Pathol; 2015; 8(5):5345-53. PubMed ID: 26191236
[TBL] [Abstract][Full Text] [Related]
93. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
94. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
95. Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.
Fei J; Xiao C; Yang M; Zhou X; Gong P
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313952
[TBL] [Abstract][Full Text] [Related]
96. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
[TBL] [Abstract][Full Text] [Related]
97. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
[TBL] [Abstract][Full Text] [Related]
98. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.
Lai H; Jin Q; Lin Y; Mo X; Li B; He K; Chen J
Tumour Biol; 2014 Oct; 35(10):10547-54. PubMed ID: 25060181
[TBL] [Abstract][Full Text] [Related]
99. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
100. Gastric juice miR-129 as a potential biomarker for screening gastric cancer.
Yu X; Luo L; Wu Y; Yu X; Liu Y; Yu X; Zhao X; Zhang X; Cui L; Ye G; Le Y; Guo J
Med Oncol; 2013 Mar; 30(1):365. PubMed ID: 23307240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
